Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03532308 · ClinicalTrials.gov registry record · Phase 3
Nutrition and Prostate Cancer
A Phase 3 study, sponsored by Yale University.
- Terminated
- Registry status
- Phase 3
- Development phase
- 19
- Enrollment target
NCT03532308 is a Phase 3 study that was terminated before completion, run by Yale University. The registered enrollment target is 19 participants.
The verdict
NCT03532308, a Phase 3 study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy of Fermented Soy vs. placebo in 72 adults with localized prostate cancer prior to radical prostatectomy.
Interventions
- OTHER Placebo
- DRUG Fermented Soy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-11-21 |
| Est. Completion | 2019-12-14 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03532308
The ClinicalTrials.gov registry entry for NCT03532308 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03532308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03532308 about?
NCT03532308 is a clinical study titled "Nutrition and Prostate Cancer". The purpose of this study is to assess the efficacy of Fermented Soy vs. placebo in 72 adults with localized prostate cancer prior to radical prostatectomy.
What is the current status of trial NCT03532308?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 19 participants. The study started on 2018-11-21. Estimated completion is 2019-12-14.
What interventions are being tested in trial NCT03532308?
The interventions under investigation include: Placebo (OTHER), Fermented Soy (DRUG).
Who is sponsoring clinical trial NCT03532308?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.